Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1993 1
1995 4
1997 1
1998 2
1999 1
2001 1
2002 2
2006 1
2009 1
2013 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Reticulocyte hemoglobin content changes after treatment of anemia of prematurity.
Nii M, Okamoto T, Sugiyama T, Aoyama A, Nagaya K. Nii M, et al. Pediatr Int. 2022 Jan;64(1):e15330. doi: 10.1111/ped.15330. Pediatr Int. 2022. PMID: 36321339
RESULTS: Reticulocyte hemoglobin content was highest at birth and declined rapidly thereafter, especially after starting rHuEPO therapy. There was no upward trend in RET-He after the initiation of oral iron supplementation, with a slower increase during 5-6 weeks after the …
RESULTS: Reticulocyte hemoglobin content was highest at birth and declined rapidly thereafter, especially after starting rHuEPO therapy …
Current controversies in the management of the anemia of prematurity.
Bishara N, Ohls RK. Bishara N, et al. Semin Perinatol. 2009 Feb;33(1):29-34. doi: 10.1053/j.semperi.2008.10.006. Semin Perinatol. 2009. PMID: 19167579 Review.
Preterm infants, especially those with extremely low birth weight (ELBW) are exposed to frequent blood draws as part of their care in the neonatal intensive care unit. ELBW infants develop the anemia of prematurity (AOP), a hypo-proliferative anemia …
Preterm infants, especially those with extremely low birth weight (ELBW) are exposed to frequent blood draws as part of their care in …
Iron status and the treatment of the anemia of prematurity.
Kling PJ, Winzerling JJ. Kling PJ, et al. Clin Perinatol. 2002 Jun;29(2):283-94. doi: 10.1016/s0095-5108(02)00002-7. Clin Perinatol. 2002. PMID: 12168242 Review.
Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether …
Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, …
Pathophysiology and treatment of the anemia of prematurity.
Attias D. Attias D. J Pediatr Hematol Oncol. 1995 Feb;17(1):13-8. doi: 10.1097/00043426-199502000-00002. J Pediatr Hematol Oncol. 1995. PMID: 7743231 Review.
Increased understanding of the pathophysiology of anemia of prematurity (AOP) has emerged over the past years. It is apparent that low levels of endogenous erythropoietin (Epo) is the basis for this phenomenon. This has resulted in an effective therapeutic ap …
Increased understanding of the pathophysiology of anemia of prematurity (AOP) has emerged over the past years. It is apparent …
Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research.
Oorschot DE, Sizemore RJ, Amer AR. Oorschot DE, et al. Int J Mol Sci. 2020 Feb 21;21(4):1487. doi: 10.3390/ijms21041487. Int J Mol Sci. 2020. PMID: 32098276 Free PMC article. Review.
Neonatal animal studies show that immediate, as well as delayed, treatment with EPO post-injury, can be neuroprotective and/or neurorestorative. The observed improvements of EPO therapy were generally not to the level of control uninjured animals, however. This suggested t …
Neonatal animal studies show that immediate, as well as delayed, treatment with EPO post-injury, can be neuroprotective and/or neurorestorat …
Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
Phibbs RH. Phibbs RH. Curr Opin Pediatr. 1995 Apr;7(2):140-5. doi: 10.1097/00008480-199504000-00004. Curr Opin Pediatr. 1995. PMID: 7787927 Review.
Anemia of prematurity (AOP) results from several interacting processes, including phlebotomy losses, a temporary failure to release erythropoietin in response to anemia, a short life span of erythrocytes, and rapid growth of body mass and, hence, blood volume …
Anemia of prematurity (AOP) results from several interacting processes, including phlebotomy losses, a temporary failure to re …
Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.
Ohls RK. Ohls RK. Paediatr Drugs. 2002;4(2):111-21. doi: 10.2165/00128072-200204020-00004. Paediatr Drugs. 2002. PMID: 11888358 Review.
Human recombinant erythropoietin has been studied extensively as treatment for a variety of anemias. Since in vitro studies showed the primary etiology of the anemia of prematurity to be insufficient serum erythropoietin concentrations, clinical trials have evaluate …
Human recombinant erythropoietin has been studied extensively as treatment for a variety of anemias. Since in vitro studies showed the prima …
Anaemia of prematurity: treatment with erythropoietin.
Carbonell-Estrany X, Figueras-Aloy J. Carbonell-Estrany X, et al. Early Hum Dev. 2001 Nov;65 Suppl:S63-7. doi: 10.1016/s0378-3782(01)00207-9. Early Hum Dev. 2001. PMID: 11755036 Review.
Anemia of prematurity is a hyporegenerative anemia usually appearing after the second week, reaching highest intensity in the second month of life. ...
Anemia of prematurity is a hyporegenerative anemia usually appearing after the second week, reaching highest intensity …
Recombinant human erythropoietin as a treatment for anemia of prematurity.
Downey P. Downey P. J Perinat Neonatal Nurs. 1997 Dec;11(3):57-68. doi: 10.1097/00005237-199712000-00007. J Perinat Neonatal Nurs. 1997. PMID: 9451192 Review.
Anemia of prematurity (AOP) is an exaggerated form of the normal physiologic anemia of infancy. ...
Anemia of prematurity (AOP) is an exaggerated form of the normal physiologic anemia of infancy. ...
Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.
Strauss RG. Strauss RG. Transfus Med Rev. 2006 Jan;20(1):34-44. doi: 10.1016/j.tmrv.2005.08.003. Transfus Med Rev. 2006. PMID: 16373186 Review.
This article will critically assess information pertaining to two of these controversies, namely, the transfusion of RBCs stored for up to 42 days after collection vs the transfusion of fresh RBCs stored 7 days or less after donation and the use of recombinant human erythropoieti …
This article will critically assess information pertaining to two of these controversies, namely, the transfusion of RBCs stored for up to 4 …
19 results